前往化源商城

9-(3-脱氧-3-氟-BETA-D-呋喃核糖基)-9H-嘌呤

更新时间:2024-01-06 18:59:08

9-(3-脱氧-3-氟-BETA-D-呋喃核糖基)-9H-嘌呤结构式
9-(3-脱氧-3-氟-BETA-D-呋喃核糖基)-9H-嘌呤结构式
品牌特惠专场
常用名 9-(3-脱氧-3-氟-BETA-D-呋喃核糖基)-9H-嘌呤 英文名 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-Purine
CAS号 124775-29-7 分子量 254.22
密度 1.9±0.1 g/cm3 沸点 544.8±60.0 °C at 760 mmHg
分子式 C10H11FN4O3 熔点 N/A
MSDS N/A 闪点 283.3±32.9 °C

 用途


9-(3-脱氧-3-氟-β-D-呋喃核糖基)-9H-嘌呤是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。

 名称

中文名 9-(3-脱氧-3-氟-BETA-D-呋喃核糖基)-9H-嘌呤
英文名 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)purine
英文别名 更多

 生物活性

描述 9-(3-脱氧-3-氟-β-D-呋喃核糖基)-9H-嘌呤是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。
相关类别
参考文献

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 物理化学性质

密度 1.9±0.1 g/cm3
沸点 544.8±60.0 °C at 760 mmHg
分子式 C10H11FN4O3
分子量 254.22
闪点 283.3±32.9 °C
精确质量 254.081512
LogP -0.20
蒸汽压 0.0±1.5 mmHg at 25°C
折射率 1.772

 英文别名

9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-9H-purine
9H-Purine, 9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-
MFCD28125312
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:

暂无推荐供应商。我要出现这里

相关化合物: 更多...
2-氨基-8-溴-9-BETA-D-呋喃核糖基-9H-嘌呤
3001-47-6
6-(2-呋喃基)-9-BETA-D-呋喃核糖基-9H-嘌呤
352025-81-1
6-氯-9-(3-C-甲基-beta-D-呋喃核糖基)-9H-嘌呤
849241-91-4
3-脱氧-3-氟-BETA-D-呋喃核糖 1-乙酸酯 2,5-二苯甲酸酯
122654-34-6
9-(2-脱氧-2-氟-BETA-D-阿拉伯呋喃糖基)-9H-嘌呤
109304-16-7
9-(2-脱氧-2-氟-BETA-D-阿拉伯呋喃糖基)-9H-嘌呤-2-胺
109304-04-3
9-[2,3,5-三-O-乙酰基-β-D-呋喃核糖基] -2,6-二氯
3056-18-6
9-[5-O-[二(4-甲氧基苯基)苯基甲基]-3-O-[[二异丙基氨基](2-氰基乙氧基)膦基]-2-O-[(叔丁基)二甲基硅烷基]-BETA-D-呋喃核糖基]-9H-嘌呤
151132-95-5
9-(2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤
690269-86-4
N-[5-[4-[4-(5-aminopent-4-enyl)cyclohexa-1,3-dien-1-yl]-2,3,4,4a,5,6,7,8-octahydronaphthalen-1-yl]-2-pyrrolidin-3-ylhexa-2,4-dienyl]-3-ethenyl-2-propylcyclohexa-1,3-dien-1-amine
130019-45-3
[4-[3-[[2-[[5-[1,7-Bis(tributylazaniumyl)heptan-4-yl]-2-hydroxy-3-methylphenyl]methylideneamino]cyclohexyl]iminomethyl]-4-hydroxy-5-methylphenyl]-7-(tributylazaniumyl)heptyl]-tributylazanium
1187992-92-2
[4-[3-[[2-[[5-[1,7-Bis(tributylazaniumyl)heptan-4-yl]-3-tert-butyl-2-hydroxyphenyl]methylideneamino]cyclohexyl]iminomethyl]-5-tert-butyl-4-hydroxyphenyl]-7-(tributylazaniumyl)heptyl]-tributylazanium
1186542-98-2
S-(fluoromethyl) 12-fluoro-6-heptan-4-yl-11-hydroxy-9,13-dimethyl-16-oxo-7-oxa-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-8-carbothioate
1954362-37-8
6-[2-[4-[(3-amino-4-chlorophenyl)methyl]phenyl]-3a-(2-hydroxyacetyl)-4,5,6,6a-tetrahydrocyclopenta[d][1,3]dioxol-5-yl]-5,8-difluoro-5-(1-hydroxybutyl)-4a-methyl-7,8-dihydro-6H-naphthalen-2-one
1431873-46-9
N-[3,5-dihydroxy-1-[(6,7,8-trihydroxycyclooct-3-en-1-yl)amino]heptan-2-yl]butanamide
2069973-27-7
15,31,47-Trichloro-4,20,36-tris(pent-2-enyl)-5,21,37-trioxatetracyclo[43.3.0.013,17.029,33]octatetraconta-1,10,14,17,26,30,33,42,46-nonaene-6,16,22,32,38,48-hexone
1421254-72-9
[5-(6-Aminopurin-9-yl)-4-hydroxy-2-[[[[3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxotetratriaconta-19,22,25,28,31-pentaenoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate
1111043-84-5
[6-[2-(3,4-Dihydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl icosa-5,8,11,14,17-pentaenoate
1613540-52-5
[5-(6-Aminopurin-9-yl)-4-hydroxy-2-[[[[3-hydroxy-4-[[3-[2-(3-hydroxyhexatriaconta-18,21,24,27,30,33-hexaenoylsulfanyl)ethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate
1010101-86-6